Pulmonary hemorrhage after pulmonary endarterectomy in a patient with chronic thromboembolic pulmonary hypertension: a case report

Massive pulmonary hemorrhage is the severe complication of pulmonary endarterectomy, associated with high mortality rates. ECMO may be a life-saving option for patients with pulmonary hemorrhage. In this case, we have described the successful sequential application of both VA and VV ECMO modalities. VA ECMO was employed initially to reduce blood flow to the right heart and pulmonary artery. Once hemodynamic stability was achieved, VV-ECMO was utilized to support severe respiratory failure. A six-month follow-up demonstrated good clinical outcome, with no evidence of pulmonary artery rethrombosis.

Authors

Institutions

Publication Details

Journal
Journal of ExtraCorporeal Technology
Published
2025-05-09
DOI
https://doi.org/10.1051/ject/2025017
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulmonary hemorrhage after pulmonary endarterectomy in a patient with chronic thromboembolic pulmonary hypertension: a case report

Г. Б. Мороз, И. А. Корнилов, Alexander Chernyavskiy, Alexander Edemskiy et al.
Journal of ExtraCorporeal Technology
Pulmonary Hypertension Research and Treatments
article

Pulmonary hemorrhage after pulmonary endarterectomy in a patient with chronic thromboembolic pulmonary hypertension: a case report

Г. Б. Мороз, И. А. Корнилов, Alexander Chernyavskiy, Alexander Edemskiy, Ramzil Nasyrtdinov
article en

Abstract

Massive pulmonary hemorrhage is the severe complication of pulmonary endarterectomy, associated with high mortality rates. ECMO may be a life-saving option for patients with pulmonary hemorrhage. In this case, we have described the successful sequential application of both VA and VV ECMO modalities. VA ECMO was employed initially to reduce blood flow to the right heart and pulmonary artery. Once hemodynamic stability was achieved, VV-ECMO was utilized to support severe respiratory failure. A six-month follow-up demonstrated good clinical outcome, with no evidence of pulmonary artery rethrombosis.

Journal of ExtraCorporeal TechnologyVol. 57(4)
Novosibirsk State Medical University (RU), Meshalkin National Medical Research Center (RU), Penn State Milton S. Hershey Medical Center (US)
Good health and well-being
Openalex Percentile: Top 85%
Pulmonary Hypertension Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.